Ravi Doddapaneni - Concepedia

Author

Ravi Doddapaneni

Florida Agricultural and Mechanical University

Also Known As

R Doddapaneni, Ravi Doddapaneni, Ravi Doddapaneni (442684)

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Florida Agricultural and Mechanical University University of Miami Texas A&M University St. John's University National Institute of Pharmaceutical Education and Research

About

Ravi Doddapaneni is an author at Florida Agricultural and Mechanical University specializing in medicine, pharmacology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	733
2	Engineering	3	3	152
3	Biomedical Engineering	3	3	152
4	Health Sciences	2	2	65
5	Biochemistry	1	1	18

Ravi Doddapaneni

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Approaches to Improve the Oral Bioavailability and Effects of Novel Anticancer Drugs Berberine and Betulinic Acid Chandraiah Godugu, Apurva R. Patel, Ravi Doddapaneni, PLoS ONE	2014	147
Inhalation delivery of Telmisartan enhances intratumoral distribution of nanoparticles in lung cancer models Chandraiah Godugu, Apurva R. Patel, Ravi Doddapaneni, Journal of Controlled Release NanoparticlesNanomedicineInhalation DeliveryEngineeringMedicine	2013	76
Novel amphiphilic lipid augments the co-delivery of erlotinib and IL36 siRNA into the skin for psoriasis treatment Cedar H. A. Boakye, Ketan Patel, Ravi Doddapaneni, Journal of Controlled Release InflammationMedicineCutaneous BiologyImmunologyPsoriatic Arthritis	2016	75
Honokiol nanomicellar formulation produced increased oral bioavailability and anticancer effects in triple negative breast cancer (TNBC) Chandraiah Godugu, Ravi Doddapaneni, Mandip Singh Colloids and Surfaces B Biointerfaces Increased Oral BioavailabilityNanomedicineHonokiol Nanomicellar FormulationMedicinePharmacology	2017	69
NR4A1 Antagonists Inhibit β1-Integrin-Dependent Breast Cancer Cell Migration Erik Hedrick, Syng‐Ook Lee, Ravi Doddapaneni, Molecular and Cellular Biology Cancer BiologyMammary Gland DevelopmentTumor BiologyNuclear Receptor 4A1Transcriptional Regulation	2016	66
Piperlongumine for Enhancing Oral Bioavailability and Cytotoxicity of Docetaxel in Triple-Negative Breast Cancer Ketan Patel, Nusrat Chowdhury, Ravi Doddapaneni, Journal of Pharmaceutical Sciences Medicinal ChemistryOral BioavailabilityOncologyPharmaceutical SciencePharmacology	2015	60
Topical Administration of Dual siRNAs Using Fusogenic Lipid Nanoparticles for Treating Psoriatic-Like Plaques Srujan Marepally, Cedar H. A. Boakye, Apurva R. Patel, Nanomedicine	2014	59
Nuclear receptor 4A1 as a drug target for breast cancer chemotherapy Erik Hedrick, Syng‐Ook Lee, Ravi Doddapaneni, Endocrine Related Cancer	2015	59
Tumor neovasculature-targeted cationic PEGylated liposomes of gambogic acid for the treatment of triple-negative breast cancer Ravi Doddapaneni, Ketan Patel, Ibtisam Hasan Owaid, Drug Delivery Breast OncologyNanotherapeuticsTumor BiologyNanomedicineParenteral Delivery	2015	58
Tumor Stromal Disrupting Agent Enhances the Anticancer Efficacy of Docetaxel Loaded PEGylated Liposomes in Lung Cancer Ketan Patel, Ravi Doddapaneni, Nusrat Chowdhury, Nanomedicine	2016	50

Page 1